Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
Growing Regenerative Medicine Market Provides Opportunities for Cytori Therapeutics
For many breast cancer patients, the effects of undergoing a mastectomy go well beyond the physical.
Healthcare Conference Updates: AUXL, CTIC, CYTX, KERX
Below are some updates and developments from the past week.
Cytori’s (NASDAQ: CYTX) Natural Celution for Breast Reconstruction
Cytori Therapeutics is a leading global innovator in the emerging field of regenerative medicine using adipose (fat) tissue as a rich source of adult stem cells capable of differentiating into a variety of cell types.